• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Radiol . 2019 novel coronavirus (COVID-19) pneumonia: CT manifestations and pattern of evolution in 110 patients in Jiangxi, China

tetano

Editor, Senior Moderator
Eur Radiol


. 2020 Aug 27.
doi: 10.1007/s00330-020-07201-0. Online ahead of print.
2019 novel coronavirus (COVID-19) pneumonia: CT manifestations and pattern of evolution in 110 patients in Jiangxi, China


Jie Zhan[SUP] 1 2 [/SUP], Haijun Li[SUP] 1 2 [/SUP], Honghui Yu[SUP] 1 2 [/SUP], Xiaochen Liu[SUP] 3 [/SUP], Xianjun Zeng[SUP] 1 2 [/SUP], Dechang Peng[SUP] 4 5 [/SUP], Wei Zhang[SUP] 6 [/SUP]



Affiliations

Abstract

Objectives: To elucidate the CT manifestations and patterns of evolution in patients with COVID-19 pneumonia.
Methods: This is a retrospective review of CT scans of 110 patients. All 110 patients had initial and second CT scans, 60 of 110 patients had three serial CT scans, and 17 of 60 patients had four serial CT scans. Numerous characteristics of pulmonary and extrapulmonary abnormalities and recognizable patterns of evolution were evaluated.
Results: Of the 110 initial CT scans, ground-glass opacities without consolidation (65.4%) were more common than a consolidation or mixed pattern. The most common findings were subpleural involvement (77.2%), multifocal involvement (80.7%), and bilateral involvement (67.3%). Three serial CT scans of 60 patients showed four patterns of CT evolution: type 1 showing relatively high CT scores on initial CT (averaged 4 days after symptom onset), with mild progression and improvement on follow-up CT scans (25%); type 2 with progression of CT findings from initial CT to first follow-up CT (averaged 9 days after symptom onset) with subsequent improvement on second follow-up CT (averaged 13 days after symptom onset, 61.7%); type 3 with no CT changes (5.0%); and type 4 pattern was similar to type 2 but with a more prolonged course and more severe CT findings (8.3%).
Conclusions: Predominant findings at initial CT scans were bilateral multifocal subpleural GGO. The most commonly shown evolution pattern was type 2: progression of disease with increased extent and density of opacities on first follow-up CT followed by improvement on second follow-up CT.
Key points: • Predominant findings at initial CT in patients with COVID-19 infection are bilateral multifocal subpleural ground-glass opacities. • Ill-defined patchy or nodular opacities were most commonly observed on CT scans with the right lower lobe most commonly involved. • The most commonly shown evolution pattern on chest CT was type 2: progression of CT findings from initial CT to first follow-up CT with subsequent improvement on second follow-up CT.

Keywords: COVID-19; Coronavirus; Infections; Pneumonia; Tomography, X-ray.
 
Back
Top Bottom